3.26
price up icon1.56%   0.05
after-market Dopo l'orario di chiusura: 3.16 -0.10 -3.07%
loading
Precedente Chiudi:
$3.21
Aprire:
$3.2
Volume 24 ore:
24,597
Relative Volume:
0.41
Capitalizzazione di mercato:
$2.76M
Reddito:
-
Utile/perdita netta:
$-11.66M
Rapporto P/E:
-0.321
EPS:
-10.156
Flusso di cassa netto:
$-11.09M
1 W Prestazione:
-0.91%
1M Prestazione:
+5.84%
6M Prestazione:
-55.81%
1 anno Prestazione:
-72.77%
Intervallo 1D:
Value
$3.05
$3.33
Intervallo di 1 settimana:
Value
$2.91
$3.35
Portata 52W:
Value
$2.40
$18.81

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Name
Nome
Phio Pharmaceuticals Corp
Name
Telefono
(508) 767-3861
Name
Indirizzo
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Name
Dipendente
9
Name
Cinguettio
@phio_pharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PHIO's Discussions on Twitter

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-08-05 Iniziato H.C. Wainwright Buy

Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie

pulisher
Nov 01, 2024

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Quantisnow

Nov 01, 2024
pulisher
Oct 24, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th - Shoreline Beacon

Oct 24, 2024
pulisher
Oct 24, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile

Oct 24, 2024
pulisher
Oct 24, 2024

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Oct 24, 2024
pulisher
Oct 23, 2024

Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile

Oct 23, 2024
pulisher
Oct 23, 2024

Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Oct 23, 2024
pulisher
Oct 18, 2024

Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail

Oct 18, 2024
pulisher
Oct 18, 2024

Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - StockTitan

Oct 18, 2024
pulisher
Oct 16, 2024

Phio Pharmaceuticals presents novel cancer therapy data - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Phio Pharmaceuticals presents novel cancer therapy data By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Yahoo Finance

Oct 16, 2024
pulisher
Oct 08, 2024

Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - Knox Daily

Oct 08, 2024
pulisher
Oct 07, 2024

Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - MSN

Oct 07, 2024
pulisher
Oct 07, 2024

Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells - Newsfile

Oct 07, 2024
pulisher
Oct 05, 2024

Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 2.5% – Time to Sell? - Defense World

Oct 05, 2024
pulisher
Oct 01, 2024

Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference - Yahoo Finance

Oct 01, 2024
pulisher
Sep 30, 2024

Nu Holdings Ltd Cl A (NU-N) QuotePress Release - The Globe and Mail

Sep 30, 2024
pulisher
Sep 26, 2024

PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan

Sep 26, 2024
pulisher
Sep 25, 2024

This trade activity should not be overlooked: Hyliion Holdings Corporation (HYLN) - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

INTASYL Technology and Compounds to be Focus of Presentation at 20th - North Bay Nugget

Sep 25, 2024
pulisher
Sep 25, 2024

INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society - Newsfile

Sep 25, 2024
pulisher
Sep 25, 2024

HITE Hedge Asset Management LLC Sells 12,931 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat

Sep 25, 2024
pulisher
Sep 25, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 24, 2024

Hyliion Holdings Corporation (HYLN) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Sep 24, 2024
pulisher
Sep 23, 2024

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Financial Metrics Unveiled: P3 Health Partners Inc (PIII)’s Key Ratios in the Spotlight - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Does Hyliion Holdings Corporation (NYSE: HYLN) Still Need To Convince Analysts? - Stocks Register

Sep 23, 2024
pulisher
Sep 23, 2024

Barrow Hanley Mewhinney & Strauss LLC Purchases Shares of 898,419 Helios Technologies, Inc. (NASDAQ:HLIO) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Hancock Whitney Corp Buys 10,920 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

PHINIA Inc. (NYSE:PHIN) Shares Acquired by Long Road Investment Counsel LLC - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

King Luther Capital Management Corp Boosts Position in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World

Sep 22, 2024
pulisher
Sep 20, 2024

Texas Permanent School Fund Corp Has $1.39 Million Stock Holdings in PHINIA Inc. (NYSE:PHIN) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Thailand's new celebrity baby pygmy hippo, Moo Deng - The Business Standard

Sep 20, 2024
pulisher
Sep 18, 2024

Bokf Na Has $58,000 Stock Position in Haleon plc (NYSE:HLN) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

American Century Companies Inc. Raises Position in PHINIA Inc. (NYSE:PHIN) - Defense World

Sep 18, 2024
pulisher
Sep 14, 2024

Contrasting Clearmind Medicine (NASDAQ:CMND) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World

Sep 14, 2024
pulisher
Sep 09, 2024

Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Devon Dispatch

Sep 09, 2024
pulisher
Sep 07, 2024

Phio Pharmaceuticals (NASDAQ:PHIO) Trading Down 0.8% - Defense World

Sep 07, 2024

Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Phio Pharmaceuticals Corp Azioni (PHIO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Bitterman Robert J
President & CEO
Jun 06 '24
Buy
0.75
1,000
750
19,990
Bitterman Robert J
President & CEO
Feb 26 '24
Buy
0.91
2,500
2,275
18,990
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):